| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
37,669 |
34,230 |
$12.06M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
36,904 |
33,175 |
$9.66M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
27,321 |
24,198 |
$8.44M |
| G0378 |
Hospital observation service, per hour |
8,185 |
5,070 |
$4.29M |
| 90832 |
Psychotherapy, 30 minutes with patient |
26,441 |
14,429 |
$3.20M |
| OP250 |
|
75,877 |
54,939 |
$1.59M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,898 |
2,579 |
$1.42M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
17,989 |
17,231 |
$1.35M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,703 |
5,105 |
$960K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
2,101 |
1,928 |
$767K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
696 |
657 |
$414K |
| 80053 |
Comprehensive metabolic panel |
45,444 |
34,648 |
$376K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
5,612 |
5,545 |
$349K |
| 71046 |
Radiologic examination, chest; 2 views |
12,074 |
11,445 |
$328K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,469 |
5,725 |
$254K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
4,189 |
3,877 |
$224K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
12,131 |
8,642 |
$209K |
| 71045 |
Radiologic examination, chest; single view |
11,507 |
9,722 |
$196K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
47,037 |
36,120 |
$194K |
| 82948 |
|
24,330 |
12,601 |
$194K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
9,415 |
8,091 |
$190K |
| 90791 |
Psychiatric diagnostic evaluation |
1,803 |
1,772 |
$183K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,349 |
2,126 |
$175K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
18,122 |
15,743 |
$175K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
370 |
364 |
$173K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,710 |
4,261 |
$167K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
150 |
142 |
$155K |
| 70486 |
|
1,267 |
1,221 |
$155K |
| OP710 |
|
12,837 |
10,828 |
$149K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13,841 |
9,854 |
$120K |
| OP370 |
|
12,720 |
10,731 |
$120K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,622 |
5,669 |
$120K |
| 76830 |
Ultrasound, transvaginal |
1,683 |
1,606 |
$117K |
| 81025 |
|
9,093 |
8,485 |
$110K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
765 |
737 |
$101K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,428 |
1,365 |
$101K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
916 |
901 |
$94K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16,386 |
14,461 |
$93K |
| OP251 |
|
13,001 |
10,035 |
$92K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,772 |
2,499 |
$89K |
| 83992 |
|
7,227 |
5,021 |
$88K |
| OP272 |
|
13,319 |
11,327 |
$87K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
10,014 |
8,710 |
$86K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,666 |
1,614 |
$86K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
11,916 |
7,548 |
$85K |
| 73630 |
|
2,562 |
2,336 |
$70K |
| 93017 |
|
1,126 |
1,057 |
$68K |
| 90837 |
Psychotherapy, 53 minutes with patient |
3,133 |
1,675 |
$62K |
| 80361 |
|
7,204 |
5,006 |
$61K |
| 30140 |
|
30 |
30 |
$59K |
| 80345 |
|
7,205 |
5,007 |
$58K |
| 80349 |
|
7,202 |
5,005 |
$58K |
| 80353 |
|
7,203 |
5,006 |
$58K |
| 80324 |
|
7,229 |
5,026 |
$58K |
| 80346 |
|
7,200 |
5,003 |
$58K |
| 36415 |
Collection of venous blood by venipuncture |
20,266 |
12,850 |
$57K |
| 80358 |
|
7,204 |
5,007 |
$54K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,691 |
3,765 |
$53K |
| 73610 |
|
2,199 |
2,051 |
$53K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
376 |
363 |
$52K |
| 81001 |
|
32,631 |
29,114 |
$50K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,611 |
3,866 |
$50K |
| 73562 |
|
2,351 |
2,206 |
$49K |
| 77080 |
|
991 |
971 |
$49K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,175 |
3,650 |
$46K |
| 72100 |
|
1,924 |
1,816 |
$45K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,906 |
2,538 |
$45K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,886 |
9,573 |
$45K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,397 |
3,104 |
$45K |
| 86850 |
|
4,224 |
3,594 |
$45K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
129 |
114 |
$43K |
| 73030 |
|
1,744 |
1,616 |
$41K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,627 |
2,979 |
$41K |
| 88342 |
|
2,656 |
2,412 |
$39K |
| 84484 |
|
12,491 |
9,005 |
$39K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,444 |
786 |
$38K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,653 |
4,977 |
$36K |
| 80061 |
Lipid panel |
3,999 |
3,561 |
$34K |
| 76770 |
|
487 |
475 |
$33K |
| 85610 |
|
13,730 |
11,449 |
$32K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
166 |
162 |
$31K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
98 |
95 |
$29K |
| 83880 |
|
4,403 |
3,647 |
$29K |
| 30802 |
|
30 |
30 |
$28K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
574 |
535 |
$28K |
| 84703 |
|
10,341 |
9,614 |
$27K |
| 85730 |
|
12,915 |
10,965 |
$27K |
| 83735 |
|
10,357 |
7,009 |
$27K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,141 |
7,285 |
$26K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
314 |
250 |
$25K |
| 73130 |
|
1,046 |
1,001 |
$24K |
| 96376 |
|
5,111 |
2,390 |
$23K |
| 93970 |
|
365 |
332 |
$23K |
| 76641 |
|
382 |
378 |
$22K |
| 84100 |
|
8,603 |
5,827 |
$21K |
| 74022 |
|
1,522 |
1,433 |
$21K |
| 88304 |
|
1,911 |
1,794 |
$21K |
| 71250 |
|
324 |
312 |
$21K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
867 |
767 |
$21K |
| 86900 |
|
4,301 |
3,675 |
$20K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
485 |
418 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,178 |
3,968 |
$20K |
| 0012A |
|
776 |
770 |
$20K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,385 |
1,322 |
$20K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,293 |
3,649 |
$19K |
| 84702 |
|
3,075 |
2,671 |
$18K |
| 0011A |
|
810 |
805 |
$18K |
| 76642 |
|
445 |
445 |
$18K |
| J2704 |
Injection, propofol, 10 mg |
9,308 |
5,329 |
$18K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,412 |
2,673 |
$17K |
| OP270 |
|
10,738 |
9,108 |
$17K |
| 73110 |
|
745 |
713 |
$17K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,222 |
1,089 |
$16K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,095 |
1,060 |
$16K |
| 80320 |
|
2,795 |
2,550 |
$16K |
| 83690 |
|
12,604 |
11,040 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,341 |
3,837 |
$15K |
| 74018 |
|
849 |
822 |
$15K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,384 |
1,319 |
$15K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
14 |
14 |
$15K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,366 |
3,007 |
$14K |
| 64483 |
|
14 |
13 |
$14K |
| 77065 |
Tomosynthesis, mammo |
292 |
292 |
$14K |
| 87430 |
|
3,122 |
3,025 |
$13K |
| 87040 |
|
3,664 |
2,476 |
$13K |
| 82803 |
|
2,839 |
2,282 |
$13K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,360 |
1,194 |
$12K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
309 |
271 |
$12K |
| 87070 |
|
4,027 |
3,826 |
$11K |
| OP258 |
|
4,017 |
1,824 |
$11K |
| 77066 |
Tomosynthesis, mammo |
238 |
238 |
$11K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,052 |
2,312 |
$11K |
| 85027 |
|
3,660 |
3,076 |
$11K |
| 97802 |
|
109 |
109 |
$10K |
| 84439 |
|
1,838 |
1,640 |
$9K |
| 73140 |
|
399 |
371 |
$8K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
715 |
666 |
$8K |
| 96367 |
|
683 |
498 |
$7K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,393 |
1,959 |
$7K |
| 76536 |
|
163 |
159 |
$6K |
| C1769 |
Guide wire |
149 |
138 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,002 |
2,327 |
$6K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
193 |
175 |
$6K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
156 |
153 |
$6K |
| 95811 |
|
13 |
13 |
$6K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,794 |
2,656 |
$6K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
26 |
26 |
$6K |
| 82550 |
|
2,583 |
2,297 |
$6K |
| 93976 |
|
39 |
35 |
$5K |
| 97162 |
|
965 |
754 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,498 |
4,403 |
$4K |
| 85378 |
|
2,457 |
2,187 |
$4K |
| 88313 |
|
320 |
308 |
$4K |
| 72040 |
|
256 |
253 |
$4K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
61 |
54 |
$4K |
| 87807 |
|
1,055 |
987 |
$4K |
| 73502 |
|
254 |
241 |
$3K |
| 82607 |
|
757 |
642 |
$3K |
| 90715 |
|
1,022 |
968 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,416 |
2,555 |
$3K |
| 70480 |
|
98 |
90 |
$3K |
| 82553 |
|
1,256 |
1,155 |
$3K |
| 10060 |
|
51 |
51 |
$3K |
| 97116 |
|
2,039 |
1,368 |
$3K |
| 87181 |
|
1,849 |
1,675 |
$3K |
| 73080 |
|
247 |
236 |
$3K |
| C9113 |
Injection, pantoprazole sodium, per vial |
4,004 |
2,407 |
$3K |
| 94150 |
|
172 |
150 |
$3K |
| 97161 |
|
376 |
319 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,352 |
6,172 |
$3K |
| 93971 |
|
85 |
81 |
$3K |
| 97803 |
|
59 |
55 |
$2K |
| 84550 |
|
44 |
40 |
$2K |
| 74240 |
|
36 |
33 |
$2K |
| 12001 |
|
122 |
120 |
$2K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
260 |
247 |
$2K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
63 |
57 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
150 |
144 |
$2K |
| 0064A |
|
76 |
74 |
$2K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
62 |
12 |
$2K |
| 71101 |
|
50 |
50 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,417 |
1,101 |
$2K |
| 82728 |
|
247 |
208 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
12 |
12 |
$1K |
| 29125 |
|
132 |
123 |
$1K |
| 82570 |
|
715 |
606 |
$1K |
| 86703 |
|
152 |
130 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,366 |
1,258 |
$1K |
| 82746 |
|
401 |
331 |
$1K |
| J2785 |
Injection, regadenoson, 0.1 mg |
87 |
55 |
$934.86 |
| 97165 |
|
322 |
217 |
$929.57 |
| 93923 |
|
54 |
54 |
$922.93 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
74 |
24 |
$909.27 |
| 94760 |
|
58 |
52 |
$865.99 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
3,775 |
885 |
$829.36 |
| 73660 |
|
12 |
12 |
$785.20 |
| 80074 |
|
77 |
61 |
$758.00 |
| 86140 |
|
415 |
331 |
$741.43 |
| 73590 |
|
44 |
41 |
$732.62 |
| 86592 |
|
77 |
65 |
$691.87 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,373 |
975 |
$665.84 |
| 0031A |
|
52 |
50 |
$664.45 |
| 88307 |
|
37 |
25 |
$631.48 |
| 70496 |
|
35 |
29 |
$631.18 |
| 70498 |
|
35 |
29 |
$631.18 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
468 |
459 |
$626.08 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
467 |
458 |
$626.08 |
| 85651 |
|
661 |
557 |
$573.28 |
| 82043 |
|
285 |
238 |
$566.57 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,095 |
388 |
$538.91 |
| 88312 |
|
131 |
130 |
$481.68 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
878 |
668 |
$448.63 |
| J2060 |
Injection, lorazepam, 2 mg |
565 |
281 |
$421.98 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
16 |
16 |
$410.38 |
| 83550 |
|
170 |
138 |
$374.54 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,830 |
1,154 |
$348.91 |
| 74019 |
|
41 |
40 |
$327.64 |
| 76801 |
|
16 |
16 |
$300.03 |
| 83540 |
|
175 |
141 |
$268.50 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
671 |
305 |
$263.03 |
| 90714 |
|
25 |
25 |
$261.90 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,682 |
746 |
$232.92 |
| 84145 |
|
18 |
18 |
$208.52 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
171 |
148 |
$202.24 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,850 |
1,265 |
$187.55 |
| 83605 |
|
136 |
93 |
$185.84 |
| 83615 |
|
57 |
49 |
$182.13 |
| 82150 |
|
17 |
16 |
$168.32 |
| 90732 |
|
24 |
24 |
$149.34 |
| 82248 |
|
59 |
53 |
$137.49 |
| 86920 |
|
16 |
13 |
$123.87 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
497 |
252 |
$120.24 |
| OP271 |
|
155 |
148 |
$110.41 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
899 |
416 |
$102.42 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
213 |
102 |
$98.04 |
| 86706 |
|
17 |
12 |
$96.25 |
| 82009 |
|
136 |
113 |
$90.52 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
593 |
386 |
$78.06 |
| OP278 |
|
46 |
43 |
$70.93 |
| 76818 |
|
12 |
12 |
$63.48 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
72 |
63 |
$62.58 |
| 82378 |
|
16 |
12 |
$62.29 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
177 |
103 |
$55.40 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
242 |
152 |
$49.22 |
| 86038 |
|
13 |
12 |
$49.01 |
| J1644 |
Injection, heparin sodium, per 1000 units |
922 |
213 |
$46.58 |
| J7510 |
Prednisolone oral, per 5 mg |
465 |
379 |
$26.64 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
830 |
444 |
$21.00 |
| 94770 |
|
34 |
33 |
$17.67 |
| 90686 |
|
15 |
15 |
$17.52 |
| 84156 |
|
66 |
51 |
$14.32 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
82 |
25 |
$13.56 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
107 |
72 |
$12.02 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
17 |
14 |
$9.12 |
| G0008 |
Administration of influenza virus vaccine |
13 |
13 |
$8.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
149 |
62 |
$4.93 |
| 97535 |
Self-care/home management training, each 15 minutes |
29 |
13 |
$2.91 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
27 |
13 |
$2.76 |
| V2632 |
Posterior chamber intraocular lens |
27 |
27 |
$2.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
108 |
68 |
$2.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
87 |
38 |
$1.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
238 |
100 |
$1.00 |
| OP255 |
|
17 |
16 |
$1.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
74 |
74 |
$0.00 |
| 97166 |
|
39 |
25 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
65 |
25 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
34 |
34 |
$0.00 |
| J3470 |
Injection, hyaluronidase, up to 150 units |
33 |
12 |
$0.00 |